SCHEMBL6138329

SCHEMBL6138329

C[C]1CC1COCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.52
LMNA P02545 1/20 0.47
TAAR1 Q96RJ0 1/20 0.44
ACHE P22303 3/20 0.43
BCHE P06276 1/20 0.43
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42
CTSK P43235 1/20 0.42
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CA1 P00915 2/20 0.40
IDO1 P14902 1/20 0.39
NAAA Q02083 1/20 0.39
PTPN1 P18031 1/20 0.39
CDC25B P30305 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5663072 0.81 TSHR (0.52) TSHRLMNATAAR1ACHEBCHE
SCHEMBL6053680 0.81 TSHR (0.52) TSHRLMNATAAR1ACHEBCHE
SCHEMBL22091837 0.77 TSHR (0.64) TSHRLMNATAAR1ACHEBCHE
SCHEMBL19190103 0.74 LMNA (0.46) TSHRLMNATAAR1ACHEBCHE
SCHEMBL17019782 0.74 TSHR (0.58) TSHRLMNATAAR1ACHEBCHE
SCHEMBL22110584 0.74 TSHR (0.58) TSHRLMNATAAR1ACHEBCHE
SCHEMBL1928095 0.74 TSHR (0.58) TSHRLMNATAAR1ACHEBCHE
SCHEMBL30210778 0.73 TSHR (0.52) TSHRLMNATAAR1ACHEBCHE
SCHEMBL6138331 0.73 TSHR (0.52) TSHRLMNATAAR1ACHEBCHE
SCHEMBL3814418 0.73 TSHR (0.52) TSHRLMNATAAR1ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1170281-B1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof SERVIER LAB (FR) 2005-12-21 EP disclosed
EP-1170281-A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof LES LABORATOIRES SERVIER (FR) 2002-01-09 EP disclosed